SCHEMBL23516006

SCHEMBL23516006

O=C1c2cccc(-n3c4ccccc4c4c(-c5ccncc5)cccc43)c2C(=O)N1c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSPA1A P0DMV8 1/20 0.43
▸ PABPC1 P11940 1/20 0.43
▸ ALDH1A1 P00352 5/20 0.42
▸ KDM4E B2RXH2 5/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ HPGD P15428 1/20 0.42
▸ HTT P42858 4/20 0.41
▸ USP2 O75604 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ MAPT P10636 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ TNNI3 P19429 1/20 0.41
▸ TNNT2 P45379 1/20 0.41
▸ TNNC1 P63316 1/20 0.41
▸ KEAP1 Q14145 1/20 0.40
▸ NFE2L2 Q16236 1/20 0.40
▸ POLB P06746 1/20 0.39
▸ APOBEC3A P31941 1/20 0.39
▸ RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23516544 0.95 PDE6D (0.45) HSPA1APABPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL23516001 0.93 HSPA1A (0.47) HSPA1APABPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL23516372 0.91 ALDH1A1 (0.44) HSPA1APABPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL23516302 0.89 HSPA1A (0.43) HSPA1APABPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL23516351 0.89 HSPA1A (0.45) HSPA1APABPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL23516250 0.89 HTT (0.44) HSPA1APABPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL23516007 0.88 PDE6D (0.48) HSPA1APABPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL23516238 0.87 HTR6 (0.34) ALDH1A1KDM4ESMN1; SMN2HPGDHTT
SCHEMBL23516353 0.85 HSPA1A (0.48) HSPA1APABPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL23516096 0.84 MAPK14 (0.40) ALDH1A1KDM4ESMN1; SMN2HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11276825-B2 Organic molecules for use in organic devices CYNORA GMBH (DE) 2022-03-15 — — US disclosed
US-20210184134-A1 ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210184134-A1 ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES CHRM1, C1S, DNMT3L HSPA1A 4232/4885PABPC1 4768/4885ALDH1A1 930/4885
US-11276825-B2 Organic molecules for use in organic devices AOX1, OR10J3, L1CAM HSPA1A 2535/4885PABPC1 2862/4885ALDH1A1 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback